130 related articles for article (PubMed ID: 9258655)
41. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
[TBL] [Abstract][Full Text] [Related]
42. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
43. Decreased or altered expression of the FHIT gene in human leukemias.
Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K
Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214
[TBL] [Abstract][Full Text] [Related]
44. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
[TBL] [Abstract][Full Text] [Related]
45. Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model.
Guo Z; Johansson SL; Rhim JS; Vishwanatha JK
Prostate; 2000 May; 43(2):101-10. PubMed ID: 10754525
[TBL] [Abstract][Full Text] [Related]
46. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
[TBL] [Abstract][Full Text] [Related]
47. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.
Hussain A; GutiƩrrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K
Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174
[TBL] [Abstract][Full Text] [Related]
48. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
[TBL] [Abstract][Full Text] [Related]
49. Loss of FHIT expression in acute lymphoblastic leukemia.
Hallas C; Albitar M; Letofsky J; Keating MJ; Huebner K; Croce CM
Clin Cancer Res; 1999 Sep; 5(9):2409-14. PubMed ID: 10499611
[TBL] [Abstract][Full Text] [Related]
50. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
51. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
52. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
[TBL] [Abstract][Full Text] [Related]
53. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue.
Tokuchi Y; Kobayashi Y; Hayashi S; Hayashi M; Tanimoto K; Hashimoto T; Nishida K; Ishikawa Y; Nakagawa K; Satoh Y; Yamamoto M; Tsuchiya E
Genes Chromosomes Cancer; 1999 Feb; 24(2):105-11. PubMed ID: 9885976
[TBL] [Abstract][Full Text] [Related]
54. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
55. Aberrant FHIT transcripts in human colorectal cancers.
Lee SH; Lee SH
Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086
[TBL] [Abstract][Full Text] [Related]
56. Abnormal transcripts of FHIT gene in Chinese brain tumors.
Tsai TC; Yang HM; Wu YL; Chi CW; Chou MD; Lee LS; Chang TJ
Oncol Rep; 1999; 6(2):345-8. PubMed ID: 10023002
[TBL] [Abstract][Full Text] [Related]
57. Aberrant FHIT transcripts in Merkel cell carcinoma.
Sozzi G; Alder H; Tornielli S; Corletto V; Baffa R; Veronese ML; Negrini M; Pilotti S; Pierotti MA; Huebner K; Croce CM
Cancer Res; 1996 Jun; 56(11):2472-4. PubMed ID: 8653678
[TBL] [Abstract][Full Text] [Related]
58. FHIT gene alterations in head and neck squamous cell carcinomas.
Virgilio L; Shuster M; Gollin SM; Veronese ML; Ohta M; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9770-5. PubMed ID: 8790406
[TBL] [Abstract][Full Text] [Related]
59. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
60. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]